Can Buscopan Be Given IV?
Yes, Buscopan (hyoscine butylbromide) can be administered intravenously. This is explicitly confirmed by FDA drug labeling and supported by multiple clinical studies demonstrating its IV use across various medical contexts 1.
Route of Administration
The FDA-approved formulation for veterinary use clearly states that Buscopan Injectable Solution (N-butylscopolammonium bromide, 20 mg/mL) is indicated for intravenous use 1. While this specific FDA label pertains to veterinary medicine (horses), the human medical literature extensively documents IV administration in clinical practice.
Clinical Evidence for IV Use
Multiple high-quality clinical trials have utilized IV hyoscine butylbromide:
- Standard IV dosing: 20 mg (1 mL of 20 mg/mL solution) administered as an intravenous injection 2, 3, 4
- Higher doses: 40 mg IV has been used as premedication in colonoscopy studies 5
- Timing: Typically given immediately before procedures or at the onset of symptoms
Clinical Applications
The IV route has been studied for:
- Gastrointestinal procedures: Colonoscopy premedication, though results showed mixed efficacy 5
- Obstetric/gynecologic procedures: Embryo transfer 2, manual vacuum aspiration 4, and labor augmentation 3
- Imaging: CT colonography, where 20 mg IV buscopan resulted in superior colonic distension compared to glucagon 6
- Abdominal pain management: As an antispasmodic for IBS and other gastrointestinal conditions 7, 8, 9
Important Considerations
Pharmacological effects: As an anticholinergic agent, IV buscopan produces expected antimuscarinic effects including:
- Transient pupillary dilation
- Dry mouth (reported in 15% of patients) 6
- Reduced gastrointestinal motility
- Potential tachycardia 10
Safety profile: The drug demonstrates good tolerability with mild adverse events. In one large trial, 75.2% of patients receiving IV buscopan reported mild adverse events compared to 57.1% in placebo group 3. Hemodynamic changes are generally of little clinical significance 1.
Alternative routes: When IV access is unavailable or impractical, intramuscular administration is also effective, though with slower onset (20-30 minutes vs 3-5 minutes for IV) 10. Subcutaneous administration has been reported in palliative care settings 11.
Practical Dosing
For IV administration in adults:
- Standard dose: 20 mg (1 mL) IV push
- Can be repeated as needed
- Onset of action: 3-5 minutes
- Duration: 30-60 minutes 10
The quaternary ammonium structure of hyoscine butylbromide means it is poorly absorbed orally and less likely to cross the blood-brain barrier compared to tertiary amines like atropine, making the parenteral route (IV or IM) more effective for acute symptom management 8.